Table 4.
Marker | NBPV | WM | GM | CSF | MD | FA |
---|---|---|---|---|---|---|
Eotaxin | -.14 | -.66* | -.10 | .29 | .37 | -.55 |
GM-CSF | .26 | -.62(*) | .24 | -.07 | -.13 | -.40 |
IFNγ | .42 | -.42 | .42 | -.32 | -.32 | -.17 |
IL-10 | --- | --- | --- | --- | --- | --- |
IL-12p40 | .28 | -.04 | .00 | -.12 | -.28 | -.08 |
IL-12P70 | --- | --- | --- | --- | --- | --- |
IL-13 | --- | --- | --- | --- | --- | --- |
IL-15 | .34 | -.47 | .44 | -.20 | -.31 | -.26 |
IL-1α | † | † | † | † | † | † |
IL-1β | --- | --- | --- | --- | --- | --- |
IL-2 | .41 | -.51 | .46 | -.26 | -.24 | -.29 |
IL-3 | .23 | -.20 | .02 | -.08 | -.08 | -.30 |
IL-4 | .36 | -.60(*) | .46 | -.26 | -.20 | -.34 |
IL-5 | --- | --- | --- | --- | --- | --- |
IL-6 | † | † | † | † | † | † |
IL-7 | .83* | -.15 | .48 | -.64 | -.51 | .12 |
IL-8 | .24 | -.37 | .07 | .02 | -.17 | -.31 |
IP-10 | .05 | -.20 | -.01 | .09 | -.17 | -.03 |
MCP-1 | -.64* | -.24 | -.83** | .77** | .66* | -.63* |
MIP-1α | .52 | -.36 | .40 | -.36 | -.36 | -.17 |
RANTES | -.36 | -.44 | -.06 | .32 | .24 | -.44 |
TNFα | .09 | -.42 | .25 | -.06 | -.08 | -.40 |
Abbreviations: NBPV:normalized parenchymal brain volume, WM: white matter, GM: gray matter, CSF: cerebrospinal fluid, MD: mean diffusivity, FA: fractional anisotropy.
Beyond limits of detection (low) in at least half of the subjects.
Beyond limits of assay detection (uniformly low) in all subjects.
p <.05;
p.01;
p<.10